EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance

Vikrant Hari Kashyap, Arti Mishra, Smita Bordoloi, Ajit Varma, Naveen Chandra Joshi iD

Mycoses · 2023-09 · 66 (9) · 737-754

DOI: 10.1111/myc.13619 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mycoses, online erschienen am 22.05.2023. Verfasst von Vikrant Hari Kashyap und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Aspergillosis, COVID-19, Pulmonary Aspergillosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspergillus fumigatus is an opportunistic pathogen that primarily affects the lungs and frequently elicits an allergic immune response in human hosts via inhalation of its airborne asexual spores (conidia). In immunocompromised individuals, the conidia of this fungus can germinate in the lung and result in severe systemic infections characterised by widespread tissue and organ damage. Conversely, in healthy hosts, the innate immune system is instrumental in eliminating the conidia and preventing disease progression. As with numerous other pathogenic fungi, A. fumigatus possesses a set of virulence factors that facilitate its infective mechanism and the circumvention of immune defences in susceptible hosts. The intrinsic capacity of A. fumigatus to form complex 3D‐structured biofilms, both on biotic and abiotic surfaces, represents a key determinant of its evasion of the host immune system and resistance to antifungal drugs. This review delineates the pivotal role of A. fumigatus biofilm structure and function as a significant virulence factor in pathogenic infections, such as aspergilloma and invasive pulmonary aspergillosis (IPA). Additionally, we discuss the importance for the development of novel antifungal drugs as drug‐resistant strains continue to evolve. Furthermore, co‐infections of A. fumigatus with other nosocomial pathogens have a substantial impact on patient's health outcomes. In this context, we provide a brief overview of COVID‐19‐associated pulmonary aspergillosis (CAPA), a recently documented condition that has gained attention due to its associated high degree of severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspergillosisCOVID-19Pulmonary AspergillosisHumansAspergillus fumigatusAntifungal AgentsVirulenceVirulence FactorsImmunityBiofilms

Stichwörter der Autor:innen

Aspergillus fumigatusCOVID-19aspergillosisbiofilm formationhost-pathogen interactionvirulence factor

Substanzen

Antifungal AgentsVirulence Factors

Autor:innen und Institutionen

  • Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK.
  • Department of Botany, Hansraj College, University of Delhi, Delhi, India.
  • Department of Life Sciences, Dibrugarh University, Dibrugarh, Assam, India.
  • Amity Institute of Microbial Technology, Amity University, Uttar Pradesh, India.

ORCID-Profile: Naveen Chandra Joshi

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Kashyap, V. H., Mishra, A., Bordoloi, S., Varma, A., & Joshi, N. C. (2023). Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance. Mycoses, 66(9), 737-754. https://doi.org/10.1111/myc.13619

Vancouver

Kashyap VH, Mishra A, Bordoloi S, Varma A, Joshi NC. Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance. Mycoses. 2023;66(9):737-754. doi:10.1111/myc.13619

BibTeX
@article{Kashyap2023,
  author = {Kashyap, Vikrant Hari and Mishra, Arti and Bordoloi, Smita and Varma, Ajit and Joshi, Naveen Chandra},
  title = {Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance},
  journal = {Mycoses},
  year = {2023},
  volume = {66},
  number = {9},
  pages = {737--754},
  doi = {10.1111/myc.13619}
}
Kostenlos starten →